Archived Insight | January 8, 2020

How to Use Compensation Survey Data: Segal Shares Insights

Myrna Hellerman, VP at Segal's Chicago office, talks to Chief Executive magazine about how companies should use compensation survey data in order to achieve the best results. Read her insights today!

Read the Interview

Questions about the article?

Get in touch. Our press team will be happy to help.

How to use compensation survey data

Myrna Hellerman speaks with Chief Executive magazine about how the data collected from compensation surveys can help companies with a variety of challenges. To successfully leverage this data, executives not only need to drill into the hard numbers, but also interpret the information collected in a way that's meaningful for their organization.

"Survey users, particularly those who seek insights into private company pay, need to rely on both the 'science' and the 'art' of data analytics."

Read more of her insights in the linked story.

Read the Interview

See more from Segal

Beyond the Horizon — 20 Years of Progress and the Journey Continues

Connect with peers at the 2026 IT Summit and learn how technology, AI and operations are shaping the future of health and pension plan administration.

Benefits Technology, ATC, Technology

Read Full Insight

Female Counselor Gives Female Client Advice

Help Your People Get the Most from Mental Health Benefits

A practical webinar for plan sponsors on improving mental health benefits engagement through plan design, workplace culture and communications.

Communications, Architecture Engineering & Construction, Healthcare Industry, Higher Education, Public Sector, Multiemployer Plans, Corporate, Health

Nurse Talking To Senior Woman In Hospital Bed

Medical Stop-Loss Premiums Increase Nearly 13%

Rising stop-loss premiums and more high-cost claims are reshaping risk for self-funded plans — see key trends from Segal’s 2026 dataset.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Get the Infographic

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.